Display Settings:

Format

Send to:

Choose Destination
Lancet. 2003 Feb 8;361(9356):489-91.

Serum test for assessment of patients with Bence Jones myeloma.

Author information

  • 1Division of Immunity and Infection, Medical School, University of Birmingham, B15 2TT, Birmingham, UK. a.r.bradwell@bham.ac.uk

Abstract

Bence Jones protein in urine (immunoglobulin free-light-chains) is characteristic of light-chain multiple myeloma. We aimed to compare a quantitative immunoassay for serum free-light-chains with urine tests. Of 224 patients with light-chain myeloma tested at entry to clinical trials, all were correctly identified from serum samples. During monitoring of 82 patients, changes in serum and urine free-light-chains corresponded, but urine became negative for free-light-chains in 26 patients, whereas it remained abnormal in serum in 73 patients. Serum assays could replace Bence Jones protein urine tests for patients with light-chain multiple myeloma.

PMID:
12583950
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk